This clinical trial is focused on improving recovery after surgery for patients undergoing robot-assisted upper urinary tract surgery, which is a type of surgery involving the kidneys or ureters. The study is particularly interested in conditions such as renal cancer, ureter cancer, benign kidney tumors, kidney stones, and kidney reflux. The trial will explore the effects of different pain management strategies during and after surgery.
Participants in the study will receive one of the following treatments: spinal morphine, which is derived from the opium poppy and administered directly into the spinal fluid, or intravenous lidocaine, a common local anesthetic given through a vein. Additionally, some patients will receive a combination of bupivacaine, another local anesthetic, and adrenaline, which helps prolong the effects of the anesthetic. The purpose of the study is to determine if these treatments can enhance recovery after surgery, as measured by a patient-centered outcome scale called “Quality of Recovery 15.”
The study will involve a random assignment of treatments to participants, and it will be conducted without the participants knowing which treatment they are receiving. The trial will monitor recovery progress, including pain levels and overall well-being, at various points after surgery. The goal is to find the most effective pain management strategy to improve the recovery experience for patients undergoing this type of surgery.



Sweden